List of works - Mourad Tayebi

A camelid anti-PrP antibody abrogates PrP replication in prion-permissive neuroblastoma cell lines

scientific article

A glycosylphosphatidylinositol analogue reduced prion-derived peptide mediated activation of cytoplasmic phospholipase A2, synapse degeneration and neuronal death.

scientific article published on 14 April 2010

A role for B lymphocytes in anti-infective prion therapies?

scientific article published on August 2007

Antibody-mediated neuronal apoptosis: therapeutic implications for prion diseases.

scientific article

Detection of protein aggregates in brain and cerebrospinal fluid derived from multiple sclerosis patients.

scientific article

Docosahexaenoic and eicosapentaenoic acids increase prion formation in neuronal cells

scientific article

Epitope-specific anti-PrP antibody toxicity: a comparative <i>in-silico</i> study of human and mouse prion proteins

scientific article published on 01 December 2021

Epitope-specific anti-prion antibodies upregulate apolipoprotein E and disrupt membrane cholesterol homeostasis.

scientific article published on 25 August 2010

Ginkgolides protect against amyloid-beta1-42-mediated synapse damage in vitro.

scientific article published on 7 January 2008

Glimepiride reduces the expression of PrPc, prevents PrPSc formation and protects against prion mediated neurotoxicity in cell lines

scientific article

Immunoinformatics Approach for Epitope-Based Peptide Vaccine Design and Active Site Prediction against Polyprotein of Emerging Oropouche Virus

scientific article published on 08 October 2018

Monoclonal antibodies inhibit prion replication and delay the development of prion disease

scientific article published in Nature

Parathyroid hormone receptor 1 (PTHR1) is a prognostic indicator in canine osteosarcoma

scientific article published on 31 January 2020

Phospholipase A2 inhibitors protect against prion and Abeta mediated synapse degeneration.

scientific article published on 8 April 2010

Plant poisoning leads to alpha-synucleinopathy and neuromelanopathy in kangaroos

scientific article published on 13 November 2019

Polyunsaturated fatty acids protect against prion-mediated synapse damage in vitro.

scientific article published on 31 July 2009

Potential candidate camelid antibodies for the treatment of protein-misfolding diseases

scientific article

PrP(Sc)-specific antibodies with the ability to immunodetect prion oligomers.

scientific article

PrP-specific camel antibodies with the ability to immunodetect intracellular prion protein

scientific article published on 7 April 2010

PrP-specific camel antibodies with the ability to immunodetect intracellular prion protein

scientific article published on 01 April 2011

PrPSc binding antibodies are potent inhibitors of prion replication in cell lines.

scientific article published on 7 May 2004

Protein conformation significantly influences immune responses to prion protein.

scientific article

Sequestration of free cholesterol in cell membranes by prions correlates with cytoplasmic phospholipase A2 activation

scientific article

The glycosylphosphatidylinositol anchor is a major determinant of prion binding and replication.

scientific article published on 28 April 2010

Unswitched immunoglobulin M response prolongs mouse survival in prion disease.

scientific article published in March 2009

List of works by Mourad Tayebi

A camelid anti-PrP antibody abrogates PrP replication in prion-permissive neuroblastoma cell lines

A glycosylphosphatidylinositol analogue reduced prion-derived peptide mediated activation of cytoplasmic phospholipase A2, synapse degeneration and neuronal death.

A role for B lymphocytes in anti-infective prion therapies?

Antibody-mediated neuronal apoptosis: therapeutic implications for prion diseases.

Detection of protein aggregates in brain and cerebrospinal fluid derived from multiple sclerosis patients.

Docosahexaenoic and eicosapentaenoic acids increase prion formation in neuronal cells

Epitope-specific anti-PrP antibody toxicity: a comparative <i>in-silico</i> study of human and mouse prion proteins

Epitope-specific anti-prion antibodies upregulate apolipoprotein E and disrupt membrane cholesterol homeostasis.

Ginkgolides protect against amyloid-beta1-42-mediated synapse damage in vitro.

Glimepiride reduces the expression of PrPc, prevents PrPSc formation and protects against prion mediated neurotoxicity in cell lines

Immunoinformatics Approach for Epitope-Based Peptide Vaccine Design and Active Site Prediction against Polyprotein of Emerging Oropouche Virus

Monoclonal antibodies inhibit prion replication and delay the development of prion disease

Parathyroid hormone receptor 1 (PTHR1) is a prognostic indicator in canine osteosarcoma

Phospholipase A2 inhibitors protect against prion and Abeta mediated synapse degeneration.

Plant poisoning leads to alpha-synucleinopathy and neuromelanopathy in kangaroos

Polyunsaturated fatty acids protect against prion-mediated synapse damage in vitro.

Potential candidate camelid antibodies for the treatment of protein-misfolding diseases

PrP(Sc)-specific antibodies with the ability to immunodetect prion oligomers.

PrP-specific camel antibodies with the ability to immunodetect intracellular prion protein

PrP-specific camel antibodies with the ability to immunodetect intracellular prion protein

PrPSc binding antibodies are potent inhibitors of prion replication in cell lines.

Protein conformation significantly influences immune responses to prion protein.

Sequestration of free cholesterol in cell membranes by prions correlates with cytoplasmic phospholipase A2 activation

The glycosylphosphatidylinositol anchor is a major determinant of prion binding and replication.

Unswitched immunoglobulin M response prolongs mouse survival in prion disease.